Table 5.
Unadjusted and adjusted analyses of neutrophil and NLR with high SHR group according to 90 days functional outcomes subgroup.
| Variables | Unadjusted model | Multivariable- Model | ||
|---|---|---|---|---|
| OR (95% CI) | p value | OR (95% CI) | p value | |
| Neutrophil, ×109/L | ||||
| mRS≤2 | 1.313(1.156-1.492) | P<0.001. | 2.284(1.525-3.420) | P<0.001 |
| mRS>2 | 1.397(1.097-1.1778) | 0.007 | 1.867 (0.900-3.873) | 0.093 |
| NLR | ||||
| mRS≤2 | 1.367(1.181-1.583) | P<0.001 | 1.377(1.164-1.629) | P<0.001 |
| mRS>2 | 1.246(1.032-1.504)) | 0.022 | 1.204(0.935-1.552) | 0.150 |
mRS≤2 Multivariable-Model: adjusted for: age, sex, DM, Hyperlipidemia, SBP, WBC, TG, TC, HDL, LDL; mRS>2 Multivariable-Model: adjusted for: age, sex, DM, SBP, DBP, WBC, LDLC. mRS: modified Rankin Scale; NLR, neutrophil-to-lymphocyte ratio; OR, odds ratio; DM, diabetes mellitus; SBP, systolic blood pressure; WBC, white blood cells; TG, triglycerides; TC, total cholesterol; HDL, high density lipoprotein; LDL, low density lipoprotein.